Therefore, to gain a better understanding of the role of necroptosis in liver inflammaging, age-associated MASLD, and lifespan, we genetically inhibited two key proteins in the necroptosis pathway, Mlkl or Ripk3, in mice. Here, RIPK3 is linked to metabolic dysfunction-associated steatotic liver disease.